MRNA
ModernaFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
MRNA vs peer average
15/100
MRNA vs. peer average (F vs. C)
Grade spread
A 2 · B 3 · C 3 · D 1 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
IONS is the first available peer comparator.
Ionis is another mid-cap R&D-heavy biotech comparison; despite a different modality, it underscores how investors focus on late-stage cadence and cash-runway visibility when commercial diversification is still incomplete.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MRNA
Moderna
IONS
Ionis
Grade
F
B
Momentum
100
15
Value
41
41
Sentiment
0
82
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs IONS
MRNA / IONS
Grade Position
Below peers
MRNA vs. peer average (F vs. C)
15/100
Momentum
100
MRNAValue
41
MRNASentiment
0
IONSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MRNA
IONS is the first peer returned for this comparison set.